index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

88

 

NOTICES

152

 

 

MOTS CLES

Cardiotoxicity Psoriasis Immune checkpoint inhibitors Auto-immune hepatitis Graft-versus-host disease Stability Antibiotic resistance Burden Biological Therapy ArtThese Autoimmunity Cardiomyopathy Biosimilar Pharmaceuticals BTK protein Ankylosing Antimicrobials Azathioprine Anti-TNF Antibiotic misuse Bacterial Arrhythmia Immunotherapy Dermatology Intensive care Cardio-oncology Quality of life Drug reaction Biologics Biologic Beta-lactam antibiotics Antibiotics Pharmacoepidemiology Treatment Adolescent Pharmacovigilance Alcohol Cancer Pharmaco-Épidémiologie Addiction Accelerometer Anxiety Antimicrobiens Abus d'antibiotiques Psoriatic arthritis Antimicrobial resistance Acute Myeloid Leukaemia AML Antimicrobial Stewardship Management Adalimumab Anti-HCV Direct Acting Antivirals DAA Arthritis CTLA-4 Angiotensin receptor blockers Apremilast ASDAS Biomarkers Aging Vigibase® Anxiété Axial spondyloarthritis Biologic drug Primary adrenal insufficiency Infliximab Biomédicaments Anti-Bacterial Agents Sipuleucel-T Ankylosing spondylitis Ethics Epidemiology Immune-related adverse events Anticancer drugs Alitretinoin Amyloidosis COVID-19 Pregnancy Atopic dermatitis Autoimmune diseases Endocrine toxicity Meta-Analysis Etanercept Access to care Drug survival Adverse side effects Albinism Spondyloarthritis Spondylitis Apre-milast Glucocorticoids Prostate cancer Bacterial rhinosinusitis Méta-Analyse Biologic therapy Biological therapy Placebo Atrial fibrillation Sacroiliitis CSK tyrosine-protein kinase Auto-Diagnostic Ustekinumab Angiotensin-converting enzyme inhibitors

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS